GELAD

DRUG2 trials

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Fudan University

Conditions

Extranodal NK-T-Cell Lymphoma, Nasal TypeNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Phase 2

Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma

RecruitingNCT06314334

Fudan UniversityNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Start: 2024-03-04End: 2028-12-30Target: 210Updated: 2026-04-09

Unknown Phase

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

CompletedNCT02733458

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineExtranodal NK-T-Cell Lymphoma, Nasal Type

Start: 2016-03-31End: 2021-04-30Updated: 2021-09-14

Related Papers

GELAD chemotherapy with sandwiched radiotherapy for patients with newly diagnosed stage IE/IIE natural killer/T‐cell lymphoma: a prospective multicentre study

British Journal of Haematology2021-11-2112 citations